Baricitinib & the Potential Disease-Modifying Therapies in Type 1 Diabetes

from Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives · host Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

Hosts discuss a recent study on baricitinib in type 1 diabetes, how these results compare to other data in this arena, and what all of these studies mean for future of type 1 diabetes management.Episode Highlights00:05 Intro01:20 Baricitinib Overview02:30 BANDIT Trial Design03:30 Trial Results05:40 Delaying Type 1 Diabetes14:45 Need for Screening 18:00 Outro

Episode metadata supplied by the publisher feed · Published Jan 3, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Baricitinib & the Potential Disease-Modifying Therapies in Type 1 Diabetes

0:00 18:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives?

This episode is 18 minutes long.

When was this Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives episode published?

This episode was published on January 3, 2024.

Can I download this Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!